Medical Facilities Corporation Reports Solid Third Quarter 2020 Financial Results
Quarter highlighted by rebound in surgical case volumes and improved profitability
TORONTO, Nov. 12, 2020 /CNW/ - Medical Facilities Corporation ("Medical Facilities," "MFC," or the "Corporation") (TSX: DR), reported its financial results today for the three-month and nine-month periods ended September 30, 2020. All amounts are expressed in U.S. dollars unless indicated otherwise.
Q3 2020 Summary
(For continuing operations1 compared to Q3 2019)
- Facility service revenue totaled $96.3 million;
- Total revenue and other income increased 2.4% to $98.8 million, including $2.5 million of government stimulus income recognized by the surgical hospitals and ambulatory surgery centers ("ASC");
- Income from operations increased to $17.6 million;
- Adjusted EBITDA2 increased 9.6% to $24.6 million; and
- St. Luke's Surgery Center of Chesterfield ("St. Luke's ASC") opened and completed its first cases in the month of September.
"We are pleased to report that case volumes continued to rebound in the third quarter despite the ongoing COVID-19 pandemic," said Robert O. Horrar, President and CEO of Medical Facilities. "Total revenue and other income for the quarter was impacted by favourable shifts in case and payor mix and government stimulus income, which were partly offset by a decline in case volumes year-over-year. We are also pleased with the progress of St. Luke's ASC, which is officially opened and operational, and is ramping up as expected."
"While uncertainty surrounding the impact of COVID-19 remains, we maintain our focus on growing MFC and seeking opportunities to execute our ASC platform growth strategy," concluded Mr. Horrar.
Financial Results
Financial Results from Continuing Operations |
For the three months ended |
For the nine months ended |
||||
September 30 |
September 30 |
|||||
(thousands of U.S. dollars, except per share amounts and where otherwise noted) |
2020 |
% change |
2019 |
2020 |
% change |
2019 |
Facility service revenue |
96,322 |
(0.2%) |
96,536 |
256,743 |
(9.6%) |
284,149 |
Government stimulus income |
2,491 |
100.0% |
- |
23,636 |
100.0% |
- |
Total revenue and other income |
98,813 |
2.4% |
96,536 |
280,379 |
(1.3%) |
284,149 |
Consolidated operating expenses |
81,241 |
(21.5%) |
103,475 |
234,186 |
(11.8%) |
265,480 |
Income (loss) from operations |
17,572 |
353.2% |
(6,939) |
46,193 |
147.4% |
18,669 |
Finance costs (net interest expense) |
2,216 |
15.8% |
1,914 |
4,567 |
(24.0%) |
6,009 |
Finance costs (changes in values of derivative instruments and gain/loss on foreign currency) |
2,076 |
110.8% |
(19,231) |
2,525 |
111.0% |
(22,872) |
Share of equity loss in associates |
672 |
100.0% |
- |
1,606 |
1,490.1% |
101 |
Income tax expense |
2,786 |
61.3% |
1,727 |
5,689 |
(12.9%) |
6,534 |
Net income |
9,822 |
13.5% |
8,651 |
31,806 |
10.1% |
28,897 |
Attributable to: |
||||||
Owners of the Corporation |
2,998 |
(38.3%) |
4,862 |
12,662 |
(16.8%) |
15,211 |
Non-controlling interest |
6,824 |
80.1% |
3,789 |
19,144 |
39.9% |
13,686 |
Earnings (loss) per share |
||||||
Basic |
$0.10 |
(37.5%) |
$0.16 |
$0.41 |
(16.3%) |
$0.49 |
Diluted |
$0.10 |
143.5% |
($0.23) |
$0.41 |
920.0% |
($0.05) |
Net income attributable to owners of the Corporation fluctuates significantly between periods, primarily due to variations in non-cash finance costs (change in the value of exchangeable interest liability), and income taxes; these charges are incurred at the corporate level rather than at the facility level.
Reconciliation of Net Income to EBITDA and Adjusted EBITDA |
For the three months ended |
For the nine months ended |
||||
September 30 |
September 30 |
|||||
(thousands of U.S. dollars, except where otherwise noted) |
2020 |
% change |
2019 |
2020 |
% change |
2019 |
Net income |
9,822 |
13.5% |
8,651 |
31,806 |
10.1% |
28,897 |
Income tax expense |
2,786 |
61.3% |
1,727 |
5,689 |
(12.9%) |
6,534 |
Share of equity loss in associates |
672 |
100.0% |
- |
1,606 |
1,490.1% |
101 |
Finance costs (income) |
4,292 |
124.8% |
(17,317) |
7,092 |
142.1% |
(16,863) |
Depreciation and amortization |
6,978 |
(5.0%) |
7,345 |
21,068 |
(8.3%) |
22,980 |
EBITDA2 |
24,550 |
5,946.8% |
406 |
67,261 |
61.5% |
41,649 |
Transaction costs on sale of Unity Medical and Surgical Hospital |
- |
- |
- |
450 |
100.0% |
- |
Impairment of goodwill |
- |
(100.0%) |
22,000 |
- |
(100.0%) |
22,000 |
Adjusted EBITDA |
24,550 |
9.6% |
22,406 |
67,711 |
6.4% |
63,649 |
Distributable Cash Flow |
For the three months ended |
For the nine months ended |
||||
September 30 |
September 30 |
|||||
(thousands of dollars, except per share amounts and percentage data) |
2020 |
% change |
2019 |
2020 |
% change |
2019 |
Cash available for distribution2 (C$) |
12,719 |
140.4% |
5,291 |
29,847 |
93.5% |
15,421 |
Distributions (C$) |
2,177 |
(75.1%) |
8,749 |
6,532 |
(75.1%) |
26,222 |
Distributions per common share (C$) |
0.07 |
(75.0%) |
0.28 |
0.21 |
(75.0%) |
0.84 |
Payout ratio2 |
17.1% |
(89.7%) |
165.3% |
21.9% |
(87.1%) |
170.2% |
During the quarter, MFC paid a quarterly cash dividend of C$0.07 per common share (or C$0.28 per share on an annualized basis), which represented an annualized yield of 6.41% on the September 30, 2020 closing price of $4.37 per common share.
As at September 30, 2020, MFC had consolidated net working capital of $54.1 million, compared to $71.5 million on December 31, 2019.
MFC's financial statements and management's discussion and analysis, for the three-month and nine-month periods ended September, 2020, will be filed on SEDAR at www.sedar.com on Thursday, November 12, 2020 and will also be available on Medical Facilities' website at www.medicalfacilitiescorp.ca.
1 Continuing operations is defined as consolidated operations excluding UMASH and RRI Mishawaka Hospital, LP which were treated as discontinued operations in the financial results for the three-month and nine-month periods ended September 30, 2020. |
2 EBITDA, adjusted EBITDA, cash available for distribution and payout ratio are non-IFRS financial measures. While Medical Facilities believes that these measures are useful for the evaluation and assessment of its performance, they do not have any standard meaning prescribed by IFRS, are unlikely to be comparable to similar measures presented by other issuers, and should not be considered as alternatives to comparable measures determined in accordance with IFRS. For further information on these non-IFRS financial measures, including a reconciliation of each of these non-IFRS financial measures to the most directly comparable measure calculated in accordance with IFRS, please refer to Medical Facilities' most recently filed management's discussion and analysis, available on SEDAR at www.sedar.com. |
Notice of Conference Call
Management of MFC will host a conference call today, November 12, 2020 at 8:30 am ET to discuss its second quarter and year-to-date financial results. All interested parties may join the conference call by dialing 647-427-7450 or 1-888-231-8191 approximately 15 minutes prior to the call to secure a line.
A live audio webcast of the call will be available at http://bit.ly/MFC2020Q3. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on MFC's website following the call date.
About Medical Facilities
Medical Facilities Corporation ("MFC"), in partnership with physicians, owns a diverse portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns controlling interest in five ambulatory surgery centers located in Michigan, Missouri, Nebraska, Ohio, and Pennsylvania. MFC also owns non-controlling interests in a specialty surgical hospital in Indiana and an ASC in Missouri. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASCs specialize in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.
Caution concerning forward-looking statements
Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties. Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions. All forward-looking statements presented herein should be considered in conjunction with such filings. Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.
SOURCE Medical Facilities Corporation
David Watson, Chief Financial Officer, Medical Facilities Corporation, 416.848.7380 or 1.877.402.7162, [email protected]; Trevor Heisler, Investor Relations, NATIONAL Capital Markets, 416.848.1434, [email protected]
Share this article